Aerovate Therapeutics Stock Investor Sentiment

AVTE Stock  USD 2.46  0.01  0.40%   
About 56% of Aerovate Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Aerovate Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Aerovate Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Aerovate Therapeutics stock news signals to limit their universe of possible portfolio assets.

Comfort Level 44

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Aerovate Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Aerovate Therapeutics.

Aerovate Historical Sentiment

Although Aerovate Therapeutics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Aerovate, such as negative comments on social media and news outlets, may cause fear in the market and push Aerovate Therapeutics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Aerovate.
  

Aerovate Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aerovate Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Aerovate Therapeutics Historical Investor Sentiment

Investor biases related to Aerovate Therapeutics' public news can be used to forecast risks associated with an investment in Aerovate. The trend in average sentiment can be used to explain how an investor holding Aerovate can time the market purely based on public headlines and social activities around Aerovate Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Aerovate Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Aerovate Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Aerovate Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Aerovate Therapeutics.
over six months ago at news.google.com         
Investment Analysts Recent Ratings Updates for Aerovate Therapeutics - Defense World
Google News at Macroaxis
over six months ago at bizjournals.com         
Waltham biotech to terminate nearly all its workforce
bizjournals News
over six months ago at investorplace.com         
The 3 Hottest Stock Downgrades From Last Week
sbwire news
over six months ago at benzinga.com         
Investigation Into Aerovate Therapeutics, Inc. Announced byHolzer Holzer, LLC
benzinga news
over six months ago at benzinga.com         
Acquisition by Benjamin Dake of 14500 shares of Aerovate Therapeutics at 10.61 subject to Rule 16b-3
benzinga news
over six months ago at benzinga.com         
Aerovate Therapeutics Investors Investigation on behalf of investors the Portnoy Law Firm
benzinga news
over six months ago at finance.yahoo.com         
Aerovate Down as Lead Drug Fails to Meet PAH Study Goals
Yahoo News
over six months ago at benzinga.com         
Acquisition by Ra Capital Management, L.p. of 928110 shares of Aerovate Therapeutics at 1.67 subject...
benzinga news
over six months ago at benzinga.com         
SHAREHOLDER ALERT Aerovate Therapeutics Investigated for Securities Fraud Violations by Block Levito...
benzinga news
over six months ago at benzinga.com         
Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluat...
benzinga news
over six months ago at benzinga.com         
Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday?
benzinga news
over six months ago at news.google.com         
Eventide Asset Management LLC Purchases Shares of 12178 Aerovate Therapeutics, Inc. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Aerovate Therapeutics, Inc. Insider George A. Eldridge Sells 15000 Shares of Stock - Defense World
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 10600 shares by Marinus Verwijs of Aerovate Therapeutics at 25.0 subject to Rule 16b-...
Macroaxis News
over six months ago at www.macroaxis.com         
Disposition of 6000 shares by Gillies Hunter of Aerovate Therapeutics at 24.5 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Aerovate Therapeutics that are available to investors today. That information is available publicly through Aerovate media outlets and privately through word of mouth or via Aerovate internal channels. However, regardless of the origin, that massive amount of Aerovate data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aerovate Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aerovate Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aerovate Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aerovate Therapeutics alpha.

Aerovate Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
INVESTOR ALERT The MA Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. - AVTE - The Eastern Progress Online
12/16/2024
2
Aerovate Therapeutics Target of Unusually Large Options Trading - MarketBeat
01/17/2025
3
Disposition of 12495 shares by George Eldridge of Aerovate Therapeutics at 31.2291 subject to Rule 16b-3
01/24/2025
4
Disposition of 10000 shares by Noyes Timothy P of Aerovate Therapeutics at 2.14 subject to Rule 16b-3
03/11/2025

Complementary Tools for Aerovate Stock analysis

When running Aerovate Therapeutics' price analysis, check to measure Aerovate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aerovate Therapeutics is operating at the current time. Most of Aerovate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aerovate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aerovate Therapeutics' price. Additionally, you may evaluate how the addition of Aerovate Therapeutics to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated